Dr. Amit Soni, M.D
Pediatric Hematology & Oncology (Pediatric Hematology & Oncology Physician)
At a glance
- Years since graduation
- 26
- In the NPI registry since
- 2008
Licensed in California since 2004, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatric Hematology & Oncology Physician primary
CA license A86383 (first issued 2004; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Childrens Hospital of Orange County (73 clinicians)
- Center for Comprehensive Care and Diagnosis of Inherited Blood Disorde (3 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Payments from drug and device companies
In 2025, 1 companies reported 11 payments worth $15,461 in total to this clinician.
| BioMarin Pharmaceutical Inc. | $15,461 |
|---|
| Travel and Lodging | $9,188 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $5,403 |
| Education | $687 |
| Food and Beverage | $182 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| BioMarin Pharmaceutical Inc. Feb 3, 2025 | Travel and Lodging travel to Milan, Italy · in-kind | $8,845 |
| BioMarin Pharmaceutical Inc. Feb 21, 2025 | Compensation for services other than consulting (speaking, faculty) ROCTAVIAN · Hemophilia A | $4,125 |
| BioMarin Pharmaceutical Inc. Dec 19, 2025 | Compensation for services other than consulting (speaking, faculty) ROCTAVIAN · Hemophilia A | $1,278 |
| BioMarin Pharmaceutical Inc. Feb 21, 2025 | Education ROCTAVIAN · Hemophilia A · in-kind | $687 |
| BioMarin Pharmaceutical Inc. Feb 21, 2025 | Travel and Lodging ROCTAVIAN · Hemophilia A · travel to Milan, Italy · in-kind | $203 |
| BioMarin Pharmaceutical Inc. Feb 21, 2025 | Travel and Lodging ROCTAVIAN · Hemophilia A · travel to Milan, Italy · in-kind | $140 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $5,851 in research payments for these studies, mostly to the institutions running them.
- A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A
Sanofi US Services Inc. · Active, not recruiting · NCT05911763 - Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
Csl Behring · Recruiting · NCT07080905
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.